TAKING A TRIP, NOT TAKING A TRIP –
Feb. 19, 2021 – A 2016 study in the Journal of Psychopharmacology found that a single dose of psilocybin mushrooms “produced substantial and enduring decreases in depressed mood and anxiety… in patients with a life-threatening cancer diagnosis.”
More than half, 54.2 percent, of participants with PTSD in a 2019 study no longer qualified as having PTSD after two doses of MDMA. The FDA classified MDMA as a “breakthrough therapy” in 2017.
The bill is co-sponsored by two veterans groups, Heroic Hearts Project and Veterans Exploring Treatment Solutions, which work to provide veterans with effective mental health treatments.
Psychedelics like LSD and psilocybin have also shown promise in treating alcoholism, according to a 2019 survey published in the Journal of Psychopharmacology
Weiner said he hopes this potential for therapeutic benefits of psychedelics is what unites people on the issue.
“Whether you’re living in San Francisco or you’re living in rural Ohio, we all — every single one of us — have experience with mental health and addiction trauma in our communities,” Weiner told Fox News. “The mental health and addiction crisis in this country is everywhere.”
Wiener also framed the bill as “part of the larger movement to end the racist War on Drugs,” which he described as “a failed set of racist policies starting in the early 20th century and accelerating in the 1970s and 1980s, established under the guise of addressing addiction and drug dealing.”
There is some evidence of racial disparities in the enforcement of drug laws. For instance, despite the fact that Black Americans and White Americans use marijuana at the same rate, Black people are 3.64 times more likely to be arrested for marijuana possession than White people, according to an American Civil Liberties Union report last year.
